Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
fda
3
×
life sciences
national blog main
3
×
national top stories
new york blog main
3
×
new york top stories
boston
drugs
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
akcea therapeutics
allopregnanolone
alnylam pharmaceuticals
andrew fire
blueprint medicines
boulder/denver blog main
boulder/denver top stories
brexanolone
cancer
companion diagnostic
craig mello
detroit blog main
detroit top stories
dna sequencing
entrectinib
express scripts
foundation medicine
hereditary transthyretin amyloidosis
indiana blog main
indiana top stories
inotersen
john maraganore
josh bilenker
keytruda
larotrectinib
What
approved
3
×
drug
fda
medicine
3
×
new
oks
specifically
afternoon
alnylam
alnylam’s
brexanolone
cancer
deeper
depression
devastating
disorder
dna
fast
fingerprint
genetic
gets
going
history
landmark
making
matter
moms
nd
ok
onpattro
partum
patisiran
pharmaceuticals
post
potentially
relief
rnai
second
targets
time
Language
Current search:
fda
×
approved
×
" national blog main "
×
" new york blog main "
×
medicine
×
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug